Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

2 Best Biotech Stocks to Buy in January

TheMotleyFool

0 0

In the past 12 months, two of the best-performing biotech stocks were cancer immunotherapy firm Fate Therapeutics (NASDAQ: FATE) and German coronavirus vaccine manufacturer BioNTech (NASDAQ: BNTX). During this period, Fate Therapeutics and BioNTech have nearly tripled or quadrupled investors' money. That kind of return is spectacular, considering that the industry benchmark, the iShares NASDAQ Biotechnology Index (NASDAQ: IBB), went up by just 44% over in the last 12 months.

Even though both stocks have gone up quite a bit, their rallies are far from finished. Here's why they can continue their momentum and add wealth to your portfolio.

Data source: YCharts.